Generate Life Sciences Supports Rutgers Cancer Institute’s Cord Blood Research With Critical Bioprocessing Device Donation

LOS ANGELES: LOS ANGELES, Oct. 13, 2021 /PRNewswire/ -- Generate Life Sciences today announced it is donating a Sepax 2 S-100 cell bioprocessing system manufactured by Cytiva to Rutgers Cancer Institute of New Jersey to support investigation of the potential efficacy of cord blood infusions in a variety of pediatric...

Click to view original post